Luther Sanjeev 4
4 · Eterna Therapeutics Inc. · Filed Jan 3, 2024
Insider Transaction Report
Form 4
Luther Sanjeev
DirectorPresident & CEO
Transactions
- Award
Stock Option (right to buy)
2024-01-01+1,685,218→ 1,685,218 totalExercise: $1.80Exp: 2034-01-01→ Common Stock, par value $0.005 per share (1,685,218 underlying)
Footnotes (1)
- [F1]Subject to continued service, 25% of the shares underlying the stock option will vest on the first anniversary of the grant date, and the remaining shares underlying the stock option will vest in 36 substantially equal monthly installments thereafter.